Payers and HTA agencies expect increasing levels of evidence, speed, and strategic clarity when evaluating health technologies. Meanwhile, internal teams are often stretched thin, facing mounting data complexity and global reimbursement variation.
AI offers a transformative opportunity to close these gaps: from accelerating evidence generation and automating dossier creation to simulating pricing negotiations and optimising launch strategies.
In this recorded webinar (10 September 2025), CELforPharma faculty member Dr Stefan Walzer shares his insights.
Continue your learning from Dr Stefan Walzer
If you’d like to learn more from Dr Stefan Walzer, CELforPharma also offers a 2-day, hands-on course where you will:
- Build a clear understanding of AI fundamentals relevant to Market Access
- Test practical AI tools for common Market Access tasks
- Learn through interactive sessions and peer exchange
The AI for Pharma Market Access Course
With Dr Stefan Walzer
And also check out Stefan's 1-day practical course on Healthcare Payer Negotiations:
The Healthcare Payer Negotiations Course
With Dr Stefan Walzer
Don’t miss future CELforPharma webinars
Subscribe to our newsletter to:
- Receive invitations to upcoming educational webinars
- Stay on top of the latest expert insights
- Get updates on our courses and training programmes